{"id":"W3213530550","doi":"10.25251/skin.5.supp.53","title":"Bimekizumab versus secukinumab efficacy across subgroups of patients with moderate to severe plaque psoriasis: Results from the multicenter, randomized, double-blinded phase 3b BE RADIANT trial","year":2021,"lang":"en","type":"article","venue":"SKIN The Journal of Cutaneous Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Queen's University","funders":"UCB Pharma","keywords":"Secukinumab; Medicine; Plaque psoriasis; Double blinded; Psoriasis; Dermatology; Randomized controlled trial; Multicenter study; Internal medicine; Psoriatic arthritis; Alternative medicine; Placebo; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002909387,0.002068135,0.004246849,0.0003332441,0.0006193249,0.001653226,0.0008650462,0.001824543,0.004213507],"category_scores_gemma":[0.002570094,0.0007552314,0.003802028,0.0004248615,0.001153321,0.001324573,0.0005343663,0.003080189,0.000785056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000719133,"about_ca_system_score_gemma":0.0008431977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006998552,"about_ca_topic_score_gemma":0.001568258,"domain_scores_codex":[0.9985949,0.0007773331,0.0001040901,0.0002432884,0.0001018009,0.0001785693],"domain_scores_gemma":[0.9987232,0.0003883305,0.0003580161,0.000147306,0.00009269664,0.0002904112],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9869071,0.001519121,0.0009869926,0.0003051113,0.001612037,0.00001932436,0.00003404491,0.0001375008,0.001341916,0.00004773662,0.0004751403,0.006614031],"study_design_scores_gemma":[0.9598463,0.03123355,0.00564508,0.0000435526,0.001823285,0.000039819,0.00003821891,0.000290386,0.000286237,0.0002420398,0.0004894472,0.00002207242],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9878616,0.006893416,0.0005357749,0.0007857159,0.0004702228,0.001091294,0.0008584732,0.0000667265,0.001436686],"genre_scores_gemma":[0.9922937,0.002048156,0.0007462045,0.001080183,0.0004618391,0.001144641,0.0009290061,0.00002476717,0.001271503],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004246849,"threshold_uncertainty_score":0.01538652,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02891430811388028,"score_gpt":0.2928783056741451,"score_spread":0.2639639975602648,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}